Amarin Corp Plc (AMRN)

[ziploc_1]

Tasty...Well said!....If Congress is interested in saving lives, they should proceed with reform of the H-W act to stop encouraging the practice of "skinny label " infringement, which is discouraging the public from getting information about life saving drugs...as well as discouraging companies from innovating to find new indications for existing drugs... Under the present scenario, once any patent for a drug is successfully challenged, all other indications for the drug in question have lost exclusivity.

A change in H-W should appeal to liberals as well as conservatives.